Indivior Swings to Pretax Loss on Higher Costs; Backs Revenue View

By Elena Vardon Indivior swung to a pretax loss for the third quarter of 2023 on higher costs, but backed its revenue expectations for the year. The...

Related Keywords

Elena Vardon , ,Article Normal ,Pharmaceuticals ,Healthcare Life Sciences ,Specialized Drugs Medications ,Financial Performance ,Earnings ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Indivior ,Indv Ln ,Uk Indv ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,